Drosik , K. (2012). Commentary [Phase III clinical trial evaluating the use pazopanib in the treatment of kidney cancer - a discussion assumptions and results of the study]. OncoReview, 2(1(5), 69-70. Retrieved from https://journalsmededu.pl/index.php/OncoReview/article/view/299